FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048409072> ?p ?o ?g. }

• W3048409072 endingPage "3952" @default.
• W3048409072 startingPage "3940" @default.
• W3048409072 abstract "To explore the safety and efficacy of intra-cavitary infusions of autologous mixed dendritic cell (DC)-cytokine-induced killer (CIK) cell products in advanced cancer patients with malignant pleural effusions or ascites. DC-CIKs were expanded ex vivo (mean yield of 1.36×109 cells (range, 0.74~4.98×109)) from peripheral blood mononuclear cells obtained by repeated venipuncture or apheresis. Patients received at least 1 cycle of 3 infusions of the DC-CIKs administered by indwelling catheter into the pleural or peritoneal cavity every other day. The volume of malignant effusions was assessed radiologically. Peripheral blood lymphocyte populations were enumerated by flow cytometry. Quality of life (QoL) during the DC-CIK infusions was assessed by the EORTC QLQ-30 instrument. ctDNA sequencing was performed to analyze gene clonal load and molecular tumor burden during the infusion treatment. Thirty-seven patients with breast, lung and other malignancies were enrolled. The results showed that intra-cavitary DC-CIK infusions (16 intrapleural and 21 intraperitoneal) were well-tolerated with no grade 3/4 adverse events. There was one complete response with effusion disappearance (CR) (3%), 13 partial responses (PR) (35%), 12 with stable disease (SD) (32%) and 11 with progressive disease (PD) (30%), resulting in a clinical effusion control rate (CCR) of 70% (26/37). The total number of infused CIKs and the CD3+/CD8+ and CD8+/CD28+ T cell frequencies within the CIKs were associated with effusion control (P=0.013). Moreover, increased peripheral blood CD3+/CD8+ (P=0.035) and decreased CD4+/CD25+ T cell frequencies (P=0.041) following the DC-CIK infusions were associated with malignant effusion and ascites control. Reductions in ctDNA correlated with clinical benefit. In conclusion, intra-cavitary autologous cellular immunotherapy is an alternative method to effectively control malignant pleural effusions and ascites. The overall effusion control rate was associated with higher peripheral blood effector T cell frequencies." @default.
• W3048409072 created "2020-08-18" @default.
• W3048409072 creator A5002520542 @default.
• W3048409072 creator A5003525882 @default.
• W3048409072 creator A5006277770 @default.
• W3048409072 creator A5021901312 @default.
• W3048409072 creator A5032451475 @default.
• W3048409072 creator A5045134210 @default.
• W3048409072 creator A5050464467 @default.
• W3048409072 creator A5062221455 @default.
• W3048409072 creator A5071949435 @default.
• W3048409072 creator A5074731037 @default.
• W3048409072 creator A5087099599 @default.
• W3048409072 date "2020-01-01" @default.
• W3048409072 modified "2023-09-23" @default.
• W3048409072 title "Clinical efficacy of intra-cavitary infusions of autologous dendritic cell/cytokine-induced killer cell products for the treatment of refractory malignant pleural effusions and ascites." @default.
• W3048409072 cites W1970881153 @default.
• W3048409072 cites W1975166857 @default.
• W3048409072 cites W1996663340 @default.
• W3048409072 cites W2040769097 @default.
• W3048409072 cites W2043685095 @default.
• W3048409072 cites W2052072562 @default.
• W3048409072 cites W2052620237 @default.
• W3048409072 cites W2055904567 @default.
• W3048409072 cites W2076668534 @default.
• W3048409072 cites W2077255241 @default.
• W3048409072 cites W2105062803 @default.
• W3048409072 cites W2134021845 @default.
• W3048409072 cites W2149714327 @default.
• W3048409072 cites W2170829864 @default.
• W3048409072 cites W2189309587 @default.
• W3048409072 cites W2353371441 @default.
• W3048409072 cites W2415138112 @default.
• W3048409072 cites W2434370167 @default.
• W3048409072 cites W2461824643 @default.
• W3048409072 cites W2581111720 @default.
• W3048409072 cites W2625028514 @default.
• W3048409072 cites W2636581712 @default.
• W3048409072 cites W2736308498 @default.
• W3048409072 cites W2770388669 @default.
• W3048409072 cites W2797807727 @default.
• W3048409072 cites W2886237000 @default.
• W3048409072 cites W2898647243 @default.
• W3048409072 cites W2902185751 @default.
• W3048409072 cites W2902941439 @default.
• W3048409072 cites W2907371372 @default.
• W3048409072 cites W2914680178 @default.
• W3048409072 cites W2942452897 @default.
• W3048409072 cites W2954180652 @default.
• W3048409072 cites W2982192686 @default.
• W3048409072 cites W2998493318 @default.
• W3048409072 cites W4235642752 @default.
• W3048409072 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7407744" @default.
• W3048409072 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32774747" @default.
• W3048409072 hasPublicationYear "2020" @default.
• W3048409072 type Work @default.
• W3048409072 sameAs 3048409072 @default.
• W3048409072 citedByCount "0" @default.
• W3048409072 crossrefType "journal-article" @default.
• W3048409072 hasAuthorship W3048409072A5002520542 @default.
• W3048409072 hasAuthorship W3048409072A5003525882 @default.
• W3048409072 hasAuthorship W3048409072A5006277770 @default.
• W3048409072 hasAuthorship W3048409072A5021901312 @default.
• W3048409072 hasAuthorship W3048409072A5032451475 @default.
• W3048409072 hasAuthorship W3048409072A5045134210 @default.
• W3048409072 hasAuthorship W3048409072A5050464467 @default.
• W3048409072 hasAuthorship W3048409072A5062221455 @default.
• W3048409072 hasAuthorship W3048409072A5071949435 @default.
• W3048409072 hasAuthorship W3048409072A5074731037 @default.
• W3048409072 hasAuthorship W3048409072A5087099599 @default.
• W3048409072 hasConcept C114684123 @default.
• W3048409072 hasConcept C126322002 @default.
• W3048409072 hasConcept C137061746 @default.
• W3048409072 hasConcept C167672396 @default.
• W3048409072 hasConcept C185592680 @default.
• W3048409072 hasConcept C202751555 @default.
• W3048409072 hasConcept C203014093 @default.
• W3048409072 hasConcept C2776232967 @default.
• W3048409072 hasConcept C2779109515 @default.
• W3048409072 hasConcept C2779634585 @default.
• W3048409072 hasConcept C2780496750 @default.
• W3048409072 hasConcept C55493867 @default.
• W3048409072 hasConcept C71924100 @default.
• W3048409072 hasConcept C8891405 @default.
• W3048409072 hasConcept C90924648 @default.
• W3048409072 hasConceptScore W3048409072C114684123 @default.
• W3048409072 hasConceptScore W3048409072C126322002 @default.
• W3048409072 hasConceptScore W3048409072C137061746 @default.
• W3048409072 hasConceptScore W3048409072C167672396 @default.
• W3048409072 hasConceptScore W3048409072C185592680 @default.
• W3048409072 hasConceptScore W3048409072C202751555 @default.
• W3048409072 hasConceptScore W3048409072C203014093 @default.
• W3048409072 hasConceptScore W3048409072C2776232967 @default.
• W3048409072 hasConceptScore W3048409072C2779109515 @default.
• W3048409072 hasConceptScore W3048409072C2779634585 @default.
• W3048409072 hasConceptScore W3048409072C2780496750 @default.
• W3048409072 hasConceptScore W3048409072C55493867 @default.
• W3048409072 hasConceptScore W3048409072C71924100 @default.

• next